Process to modulate disease risk with doses of a nutraceutical
US6630160B1 · kind B1 · utility
27Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2000 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Sep 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
A dietary supplement is created, comprised of material from the following nutrients, vitamins, herbs, minerals, and food and plant substances and food and plant derivatives: lycopene, vitamin E, selenium, green tea, coenzyme Q10, garlic, folic acid, vitamin C, curcumin, seaweed, Cordyceps sinsensis mushroom, Lentinus edodes (shiitake) mushroom, and Ganoderma lucidum (reishi) mushroom. The composition is administered orally for individuals who wish to reduce their risk of disease, particularly cancer-risk.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.